MSCs sourced from placental amniotic membrane.
Mesenchymal stem cells (MSCs) derived from placental tissue—amnion, chorion, or decidua—collected after birth without harm. Placental MSCs are abundant, expand readily in culture, and retain strong immunomodulatory and anti-inflammatory properties. They're less immunogenic than bone-marrow MSCs, making them suitable for allogeneic use. Clinics using placental MSCs over bone marrow are often employing a well-established alternative with practical scaling advantages. Ask whether they harvest from vaginal or caesarean deliveries (different tissue composition) and whether they've validated immunophenotype (CD90, CD105, CD34 markers) to ensure consistency across batches.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment